Nalaganje...
Targeting resistance to targeted therapies: combating a resilient foe
While the advent of third generation therapies have dramatically changed the treatment paradigm for EGFR mutated lung cancer, resistance to these agents inevitably emerges. Understanding resistance mechanisms and their genomic underpinnings is crucial for developing innovative strategies that are ca...
Shranjeno v:
| izdano v: | Clin Cancer Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6295273/ https://ncbi.nlm.nih.gov/pubmed/30352903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3178 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|